BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

11.30
Delayed Data
As of May 21
 -0.09 / -0.79%
Today’s Change
7.85
Today|||52-Week Range
14.62
-7.07%
Year-to-Date

Today’s Trading

Previous close11.39
Today’s open11.37
Day’s range-- - --
Volume410,095
Average volume (3 months)903,149
Market cap$826.0M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)-49.63%
Earnings growth (next 5 years)-4.23%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book10.84

Competitors

 Today’s
change
Today’s
% change
OVASOvaScience Inc-1.56-4.77%
BPMCBlueprint Medicines ...+0.12+0.41%
IMGNImmunoGen Inc+0.12+1.38%
RTRXRetrophin Inc-0.05-0.19%
Data as of 05/21/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Chief Financial Officer, Treasurer, CAO &
SVP
Thomas R. Staab
Corporate headquarters
Birmingham, Alabama

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers